Rating History for Adamas Pharmaceuticals (ADMS) by BofA Securities
Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|
9/30/2019 | N/A | Downgrade | Underperform (Neutral) |
N/A (N/A) |
6.66 (8.22) |
23.42% | Details |
Date | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
---|---|---|---|---|---|---|---|
9/30/2019 | N/A | Downgrade | Underperform (Neutral) |
N/A (N/A) |
6.66 (8.22) |
23.42% | Details |